Կանադա - անգլերեն - Health Canada

perlier inc. - avobenzone; octinoxate; octisalate; octocrylene; oxybenzone - cream - 0.9%; 7.5%; 2.0%; 5.0%; 0.6% - avobenzone 0.9%; octinoxate 7.5%; octisalate 2.0%; octocrylene 5.0%; oxybenzone 0.6% - sunscreen agents

Կանադա - անգլերեն - Health Canada

perlier inc. - avobenzone; octinoxate; octisalate; octocrylene; oxybenzone - cream - 0.9%; 7.5%; 2.0%; 5.0%; 0.6% - avobenzone 0.9%; octinoxate 7.5%; octisalate 2.0%; octocrylene 5.0%; oxybenzone 0.6% - sunscreen agents

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

ebpd llc - avobenzone (unii: g63qqf2nox) (avobenzone - unii:g63qqf2nox), ensulizole (unii: 9yq9di1w42) (ensulizole - unii:9yq9di1w42), octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), octocrylene (unii: 5a68wgf6wm) (octocrylene - unii:5a68wgf6wm) - - helps prevent sunburn. - if used as directed with other sun protection measures (see directions ) decreases the risk of skin cancer and early skin aging caused by the sun.

Ավստրալիա - անգլերեն - APVMA (Australian Pesticides and Veterinary Medicines Authority)

certis u.s.a. l.l.c. - bacillus thuringiensis subsp. berliner var. kurstaki - unknown - bacillus thuringiensis subsp. berliner var. kurstaki biological-organism-bt active 0.0 - active constituent

Ավստրալիա - անգլերեն - APVMA (Australian Pesticides and Veterinary Medicines Authority)

colin campbell (chemicals) pty ltd - bacillus thuringiensis berliner subsp aizawai - water dispersible granule - bacillus thuringiensis berliner subsp aizawai biological-organism-bt active 0.0 undefined - insecticide - agricultural non-crop areas | amenity tree | cereal grain | forestry | fruit | herb | macadamia | oilseed crop | ornamental | to - armyworm | cabbage moth | cabbage white butterfly | cotton budworm or bollworm | light brown apple moth | looper | native budworm or bollworm | susceptible insect species - see label | vine moth | corn earworm | cotton bollworm | diamondback moth | heliothis | looper caterpillars | native bollworm | spodoptera spp. | tobacco budworm | tomato grub

Ավստրալիա - անգլերեն - APVMA (Australian Pesticides and Veterinary Medicines Authority)

certis u.s.a. l.l.c. - bacillus thuringiensis berliner subsp aizawai - water dispersible granule - bacillus thuringiensis berliner subsp aizawai biological-organism-bt active 0.0 u - insecticide - amenity tree | cereal grain | cotton | forestry | fruit crop | herb | macadamia | oilseed crop | ornamental | tobacco | turf | v - armyworm | cabbage moth | cabbage white butterfly | cotton budworm or bollworm | grapevine moth | light brown apple moth | looper moth | native budworm or bollworm | painted vine moth | pear looper | soybean looper | corn earworm | cotton bollworm | diachrysia orichalceaa | diamondback moth | heliothis | native bollworm | spodoptera spp. | tobacco budworm | tomato grub | twig looper

Ավստրալիա - անգլերեն - APVMA (Australian Pesticides and Veterinary Medicines Authority)

titan ag pty ltd - bacillus thuringiensis berliner.subsp.israelensis - unknown - bacillus thuringiensis berliner.subsp.israelensis biological-organism-bt-berline active 0.0 - active constituent

Ավստրալիա - անգլերեն - APVMA (Australian Pesticides and Veterinary Medicines Authority)

valent biosciences a div of sumitomo chemical australia - bacillus thuringiensis berliner subsp kurstaki - unknown - bacillus thuringiensis berliner subsp kurstaki biological-organism-bt active 0.0 - active constituent

Իսրայել - անգլերեն - Ministry of Health

boehringer ingelheim israel ltd. - alteplase - powder and solvent for solution for injection/infusion - alteplase 50 mg/vial - enzymes - acute myocardial infarction :actilyse is indicated for use in the management of acute myocardial infraction (ami) in adults for the lysis of thrombi obstructing coronary arteries, the reduction of infract size, improvement of ventricular function, the reduction of the incidence of congestive heart failure and the reduction of mortality associated with ami. treatment should be initiated as soon as possible after the onset of ami symptoms.acute massive pulmonary embolism with hemodynamic deprivation:actylise is indicated in the management of acute massive pulmonary embolism (pe) in adults:- for the lysis of acute pulmonary emboli, defined as obstruction of blood flow to a lobe or multiple segments of the lung, and- for the lysis of pulmonary emboli accompanied by unstable hemodynamics e.g. failure to maintain blood pressure without supportive measures. the diagnosis should be confirmed by objective means, such as pulmonary angiography or noninvasive procedures such as lung scanning. for fibrinolytic treatment of acute ischaemic stroke.treatment must be started as early as possible within 4.5 hours after onset of stroke symptoms and after exclusion of intracranial haemorrhage by appropriate imaging techniques (e.g. cranial computerised tomography or other diagnostic imaging method sensitive for the presence of haemorrhage). the treatment effect is time-dependent; therefore earlier treatment increases the probability of a favourable outcome. this treatment is restricted to a prescription by a specialist in neurology.

Իսրայել - անգլերեն - Ministry of Health

boehringer ingelheim israel ltd. - alteplase - powder and solvent for solution for injection/infusion - alteplase 20 mg/vial - enzymes - acute myocardial infarction :actilyse is indicated for use in the management of acute myocardial infraction (ami) in adults for the lysis of thrombi obstructing coronary arteries, the reduction of infract size, improvement of ventricular function, the reduction of the incidence of congestive heart failure and the reduction of mortality associated with ami. treatment should be initiated as soon as possible after the onset of ami symptoms.acute massive pulmonary embolism with hemodynamic deprivation:actylise is indicated in the management of acute massive pulmonary embolism (pe) in adults:- for the lysis of acute pulmonary emboli, defined as obstruction of blood flow to a lobe or multiple segments of the lung, and- for the lysis of pulmonary emboli accompanied by unstable hemodynamics e.g. failure to maintain blood pressure without supportive measures. the diagnosis should be confirmed by objective means, such as pulmonary angiography or noninvasive procedures such as lung scanning. for fibrinolytic treatment of acute ischaemic stroke.treatment must be started as early as possible within 4.5 hours after onset of stroke symptoms and after exclusion of intracranial haemorrhage by appropriate imaging techniques (e.g. cranial computerised tomography or other diagnostic imaging method sensitive for the presence of haemorrhage). the treatment effect is time-dependent; therefore earlier treatment increases the probability of a favourable outcome. this treatment is restricted to a prescription by a specialist in neurology.